Investors
ImmunoPrecise’s proprietary technologies and products are positioned on the leading edge of antibody development, innovating our industry as a single source provider of the full complement of antibody discovery platforms. As an investor in ImmunoPrecise Antibodies, you’re joining us at the forefront of new, exciting, and valuable advancements in next-generation antibody discovery.
ImmunoPrecise Antibodies Ltd. Stock Information
For more information, please review our Stock Quotes and Charts, Investor Presentation or visit our News Releases page.
For more information, please review our Stock Quotes and Charts, Investor Presentation or visit our News Releases page.
For more information, please review our Stock Quotes and Charts, Investor Presentation or visit our News & Releases page.
Investor Relations
For investor inquiries please contact: investors@immunoprecise.comFinancial Statements
Please find our financials on Sedar in English and Français.Analyst Coverage
Download August 2, 2022 Report Download October 25, 2021 Report Robert Wasserman +1 (212) 312-6764Earnings Call
The Company held an earnings conference call via webcast on July 29th, 2022.
View a recording of the earnings call or view the transcript.